Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous Malformations
Clinical trial NCT02042326 · RECRUITING
Trial details
- NCT number
- NCT02042326
- Sponsor
- Centre Hospitalier Universitaire, Amiens
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-12
- Primary completion
- 2027-09-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.